| Literature DB >> 8373918 |
A C Power1, C E Dorkins, P J Cowen.
Abstract
We assessed the effect of two regimens of lithium treatment (3 days and 2 weeks) on brain serotonin (5-HT) function in healthy subjects by measuring the prolactin (PRL) responses to the 5-HT releasing agent, d-fenfluramine (30 mg) before and after lithium administration. Neither regime of lithium treatment altered d-fenfluramine-induced PRL release. These results are in contrast to the facilitation produced by lithium of the PRL responses to the 5-HT precursor L-tryptophan. The data suggest that the ability of lithium to increase brain 5-HT neurotransmission in humans may depend on interactions with particular 5-HT receptor subtypes or specific mechanisms of 5-HT release.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8373918 DOI: 10.1016/0006-3223(93)90021-5
Source DB: PubMed Journal: Biol Psychiatry ISSN: 0006-3223 Impact factor: 13.382